Reading time is 1 mins


In scientific cooperation with the Turkish Health Institutes presidency (TÜSEB) and Erciyes University (ERU) Vaccine Research and Development Center (ERAGEM), voluntary applications for Phase-3 studies of the domestic vaccine developed against the corona virus in Turkey began via e-Pulse.

* A Phase-1 Study of the Covid-19 native vaccine developed by TÜSEB and ERAGEM against coronavirus was conducted on 44 volunteers.

* Phase-2 studies of the inactive vaccine began in February, and 250 volunteers completed the vaccine on April 9. At the end of April, Phase-2 reporting was completed.

* In the reporting, it was determined that 100 percent of the volunteers who received the corona virus vaccine had antibodies. Then, in May, Phase-3 work began.

* In this context, voluntary recruitment via e-Pulse was started. On his E-pulse page, he said, “volunteer for the vaccine study. Click here to volunteer in Phase-3 clinical trials of the inactive Covid-19 vaccine developed in cooperation with the Turkish Health Institutes and Erciyes University.”


Applications for those who want to volunteer in the Phase-3 study of the Covid-19 vaccine developed by Erciyes University have begun to be received. The Turkish Health Minister called for voluntary phase-3 via e-Pulse.

Among the domestic vaccines developed against the corona virus in Turkey, human experiments were first started and Phase-1 and Phase-2 phase were completed in the Covid-19 Vaccine of Erciyes University, which reached Phase-3. The Department of Health has opened a ‘volunteer’ button on the E-Pulse app for those who want to volunteer in the Phase-3 study.


Health Minister, in a statement on his Twitter account, said the domestic vaccine was in the final stage, calling on citizens to volunteer for Phase-3. “Our domestic vaccine is in the final stage. Volunteer in the Phase 3 human study, let’s achieve the result together” with the message “The inactive Covid-19 Turkish vaccine developed in cooperation with Ministry of Health, Presidency of Turkish Institutes of Health, Kayseri Erciyes University and reached the final stage in the Phase 3 human study.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me